World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
11182
World Ranking
15032
National Ranking
6290

Overview

Russell O. Pieper is affiliated with the University of California, San Francisco in the United States and works primarily within the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their research spans several subfields, including Molecular Biology, Genetics, Cancer Research, Radiology, Nuclear Medicine and Imaging, and Physiology.

Their work addresses a range of scientific topics with a focus on areas such as Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, Advanced MRI Techniques and Applications, Telomeres, Telomerase, and Senescence, Mitochondrial Function and Pathology, DNA Repair Mechanisms, and Cancer Genomics and Diagnostics.

Russell O. Pieper has collaborated frequently with several researchers, including Sabrina M. Ronen, Pavithra Viswanath, J Costello, Joydeep Mukherjee, and Georgios Batsios.

Their most frequent publication venues include Neuro-Oncology, Neuro-Oncology Advances, Cell Reports, WFNOS 2022 Abstract Book, and Nature Communications. Within these venues, they have contributed predominantly to Neuro-Oncology and Neuro-Oncology Advances.

Notable recent papers by Russell O. Pieper include:

  • Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas, 2021, Neuro-Oncology
  • Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma, 2020, Neuro-Oncology Advances
  • Non-invasive assessment of telomere maintenance mechanisms in brain tumors, 2021, Nature Communications
  • Retracted: Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity, 2020, Cell Reports
  • MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma, 2020, Theranostics

Best Publications

  • Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

    Andrew T Parsa;James S Waldron;Amith Panner;Courtney A Crane

  • p53 Effects Both the Duration of G2/M Arrest and the Fate of Temozolomide-treated Human Glioblastoma Cells

    Yuichi Hirose;Mitchel S. Berger;Russell O. Pieper

  • Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.

    Jeffrey C Lee;Jeffrey C Lee;Igor Vivanco;Rameen Beroukhim;Rameen Beroukhim;Julie H. Y Huang

  • DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells

    M Katayama;T Kawaguchi;M S Berger;R O Pieper

  • Abrogation of the Chk1-mediated G2 Checkpoint Pathway Potentiates Temozolomide-induced Toxicity in a p53-independent Manner in Human Glioblastoma Cells

    Yuichi Hirose;Mitchel S. Berger;Russell O. Pieper

  • Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.

    Yukihiko Sonoda;Tomoko Ozawa;Yuichi Hirose;Ken D. Aldape

  • Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

    George S. Watts;Russell O. Pieper;Joseph F. Costello;Yei Mei Peng

  • PTEN and Hypoxia Regulate Tissue Factor Expression and Plasma Coagulation by Glioblastoma

    Yuan Rong;Dawn E. Post;Russell O. Pieper;Donald L. Durden

  • Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma

    Yukihiko Sonoda;Tomoko Ozawa;Ken D. Aldape;Dennis F. Deen

  • Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells

    Joseph F. Costello;Bernard W. Futscher;Keizo Tano;Dawn M. Graunke

  • Contribution of Notch signaling activation to human glioblastoma multiforme

    Masayuki Kanamori;Tomohiro Kawaguchi;Janice M. Nigro;Burt G. Feuerstein

  • PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer

    C A Crane;A Panner;J C Murray;S P Wilson

  • mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells

    Amith Panner;C. David James;Mitchel S. Berger;Russell O. Pieper

  • Convection-Enhanced Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand with Systemic Administration of Temozolomide Prolongs Survival in an Intracranial Glioblastoma Xenograft Model

    Ryuta Saito;John R. Bringas;Amith Panner;Matyas Tamas

  • Lactate dehydrogenase A silencing in IDH mutant gliomas.

    Charles Chesnelong;Myriam M. Chaumeil;Michael D. Blough;Mohammad Al-Najjar

  • The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents

    Yuichi Hirose;Makoto Katayama;David Stokoe;Daphne A. Haas-Kogan

  • Akt Activation Suppresses Chk2-Mediated, Methylating Agent–Induced G2 Arrest and Protects from Temozolomide-Induced Mitotic Catastrophe and Cellular Senescence

    Yuchi Hirose;Makoto Katayama;Olga K. Mirzoeva;Mitchel S. Berger

  • Methylation-related chromatin structure is associated with exclusion of transcription factors from and suppressed expression of the O-6-methylguanine DNA methyltransferase gene in human glioma cell lines.

    Joseph F. Costello;Bernard W. Futscher;Roger A. Kroes;Russell O. Pieper

  • The Receptor Interacting Protein 1 Inhibits p53 Induction through NF-κB Activation and Confers a Worse Prognosis in Glioblastoma

    Seongmi Park;Kimmo J. Hatanpaa;Yang Xie;Bruce E. Mickey

  • Non-invasive in vivo assessment of IDH1 mutational status in glioma

    Myriam M. Chaumeil;Peder E. Z. Larson;Hikari A. I. Yoshihara;Olivia M. Danforth

Frequent Co-Authors

Joanna J. Phillips
Joanna J. Phillips University of California, San Francisco
Joseph F. Costello
Joseph F. Costello University of California, San Francisco
Mitchel S. Berger
Mitchel S. Berger University of California, San Francisco
Andrew T. Parsa
Andrew T. Parsa Northwestern University
Bernard W. Futscher
Bernard W. Futscher University of Arizona
Sarah J. Nelson
Sarah J. Nelson University of California, San Francisco
J. Gregory Cairncross
J. Gregory Cairncross University of Calgary
Daniel B. Vigneron
Daniel B. Vigneron University of California, San Francisco
Samuel Weiss
Samuel Weiss University of Calgary
C. David James
C. David James Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry can lead to a wide range of rewarding careers in healthcare, research, and beyond. For those interested in advancing their education or changing their career path, there are many flexible online options to consider.

Healthcare professionals looking to specialize may explore online fnp programs to become Family Nurse Practitioners. If you’re passionate about nutrition, a dietician degree online is a valuable credential that can open doors in hospitals, wellness centers, and public health.

Registered nurses ready for advancement can consider rn to bsn online programs to broaden their career opportunities. Additionally, students seeking leadership roles might pursue the fastest online master's in healthcare administration programs to quickly gain management expertise.

Whether you are just starting out or advancing your current qualifications, these related online degree pathways provide flexible and affordable routes to success in the health and science sectors.

Best Scientists Citing Russell O. Pieper

Trending Scientists